Successful living donor liver transplantation of fulminant liver failure due to isoniazid prophylaxis

dc.authorscopusid54411989700
dc.authorscopusid8587623600
dc.authorscopusid56020996800
dc.authorscopusid56574835700
dc.contributor.authorÇakir T.
dc.contributor.authorAra C.
dc.contributor.authorSoyer H.V.
dc.contributor.authorKoc S.
dc.date.accessioned2024-08-04T20:02:34Z
dc.date.available2024-08-04T20:02:34Z
dc.date.issued2015
dc.departmentİnönü Üniversitesien_US
dc.description.abstractProgressive liver failure is rarely seen in tuberculosis chemoprophylaxis with isoniazid. We present a case of a 32-year-old woman admitted to our clinic reporting abdominal pain, nausea and vomiting for 2 days. The initial diagnosis was fulminant toxic hepatitis due to isoniazid chemoprophylaxis, which was treated successfully with living donor transplantation. Tuberculosis continues to be a significant public health problem. Isoniazid-related hepatotoxicity is extremely rare in adults. The only treatment in cases of fulminant liver failure is orthotopic liver transplantation from a deceased or living donor. If a deceased donor is not available or the patient refuses this treatment, living donor transplantation is the only choice. Although rare, isoniazid used as protective therapy for pulmonary tuberculosis can lead to fulminant liver failure. When cadaveric liver transplantation is not available, living donor liver transplantation is vital. © 2015 CrossMark.en_US
dc.identifier.doi10.1136/bcr-2015-209448
dc.identifier.issn1757-790X
dc.identifier.pmid26106175en_US
dc.identifier.scopus2-s2.0-84938889344en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://doi.org/10.1136/bcr-2015-209448
dc.identifier.urihttps://hdl.handle.net/11616/91802
dc.identifier.volume2015en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.ispartofBMJ Case Reportsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectalanine aminotransferaseen_US
dc.subjectalbuminen_US
dc.subjectammoniaen_US
dc.subjectaspartate aminotransferaseen_US
dc.subjectbilirubinen_US
dc.subjectC reactive proteinen_US
dc.subjectcreatinineen_US
dc.subjectgamma glutamyltransferaseen_US
dc.subjecthemoglobinen_US
dc.subjectisoniaziden_US
dc.subjectmethylprednisoloneen_US
dc.subjectnitrogenen_US
dc.subjecttacrolimusen_US
dc.subjectureaen_US
dc.subjectisoniaziden_US
dc.subjecttuberculostatic agenten_US
dc.subjectabdominal painen_US
dc.subjectadulten_US
dc.subjectarterial gasen_US
dc.subjectArticleen_US
dc.subjectbrain diseaseen_US
dc.subjectcase reporten_US
dc.subjectchemoprophylaxisen_US
dc.subjectconsciousness disorderen_US
dc.subjectdeliriumen_US
dc.subjectdisease associationen_US
dc.subjectdisease durationen_US
dc.subjectdisease exacerbationen_US
dc.subjectdrug blood levelen_US
dc.subjectdrug withdrawalen_US
dc.subjectfemaleen_US
dc.subjectfulminant hepatic failureen_US
dc.subjecthumanen_US
dc.subjecthuman tissueen_US
dc.subjectimmunosuppressive treatmenten_US
dc.subjectinternational normalized ratioen_US
dc.subjectjaundiceen_US
dc.subjectlength of stayen_US
dc.subjectleukocyte counten_US
dc.subjectliver graft rejectionen_US
dc.subjectliver toxicityen_US
dc.subjectliver transplantationen_US
dc.subjectliving donoren_US
dc.subjectmultidetector computed tomographyen_US
dc.subjectnausea and vomitingen_US
dc.subjectpartial thromboplastin timeen_US
dc.subjectpriority journalen_US
dc.subjectprothrombin timeen_US
dc.subjectsomnolenceen_US
dc.subjectthrombocyte counten_US
dc.subjecttuberculosisen_US
dc.subjecturea nitrogen blood levelen_US
dc.subjectchemically induceden_US
dc.subjectLiver Failure, Acuteen_US
dc.subjecttuberculosisen_US
dc.subjectAdulten_US
dc.subjectAntitubercular Agentsen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectIsoniaziden_US
dc.subjectLiver Failure, Acuteen_US
dc.subjectLiver Transplantationen_US
dc.subjectLiving Donorsen_US
dc.subjectTuberculosisen_US
dc.titleSuccessful living donor liver transplantation of fulminant liver failure due to isoniazid prophylaxisen_US
dc.typeArticleen_US

Dosyalar